SPARC antagonizes the effect of basic fibroblast growth factor on the igration of bovine aortic endothelial cells

Migration of endothelial cells is requisite to wound repair and angiogenesis. Since the glycoprotein SPARC (secreted protein, acidic and rich in cysteine) is associated with remodeling, cellular migration, and angiogenesis in vitro, we questioned whether SPARC might influence the motility of endothelial cells. In this study we show that, in the absence of serum, exogenous SPARC inhibits the migration of bovine aortic endothelial cells induced by bFGF. Similar results were obtained from two different assays, in which cell migration was measured in a Boyden chamber and in monolayer culture after an experimental wound. Without bFGF, the migration of endothelial cells was unaffected by SPARC. The inhibitory effect of SPARC on cell motility was dose‐dependent, required the presence of Ca2+, was mimicked by synthetic peptides from the N‐ and C‐terminal Ca2+‐binding domains of the protein, and was not seen in the presence of serum. Modulation of the activities of secreted and cell‐associated proteases, including plasminogen activators and metalloproteinases, appeared not to be responsible for the effects that we observed on the motility of endothelial cells. Moreover, a molecular interaction between SPARC and bFGF was not detected, and SPARC did not interfere with the binding of bFGF to high‐affinity receptors on endothelial cells. Finally, in culture medium that contained serum, SPARC inhibited the incorporation of [3H]‐thymidine into newly synthesized DNA, both in the absence and presence of bFGF. However, DNA synthesis was not affected by SPARC when the cells were plated on gelatin or fibronectin in serum‐free medium. We propose that the combined action of a serum factor and SPARC regulates both endothelial cell proliferation and migration and coordinates these events during morphogenetic processes such as wound repair and angiogenesis.

[1]  E. Sage,et al.  Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cells. , 1992, Experimental cell research.

[2]  R. Ross,et al.  The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  E. Sage,et al.  SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells. , 1991, The Journal of biological chemistry.

[4]  E. Sage,et al.  The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Isacchi,et al.  A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. Kohno,et al.  Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor. , 1991, Experimental cell research.

[7]  M. Iruela-Arispe,et al.  Differential expression of extracellular proteins is correlated with angiogenesis in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[8]  E. Sage,et al.  Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape , 1990, The Journal of cell biology.

[9]  P. Jensen,et al.  A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration. , 1990, Cell regulation.

[10]  L. Orci,et al.  The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes , 1990, The Journal of cell biology.

[11]  D. Rifkin,et al.  Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells , 1990, The Journal of cell biology.

[12]  N. Quarto,et al.  Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin , 1989, The Journal of cell biology.

[13]  M. Presta,et al.  The mitogenic signaling pathway but not the plasminogen activator- inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells , 1989, The Journal of cell biology.

[14]  Donald E. Ingber,et al.  How does extracellular matrix control capillary morphogenesis? , 1989, Cell.

[15]  P. Mcneil,et al.  Growth factors are released by mechanically wounded endothelial cells , 1989, Journal of Cell Biology.

[16]  E. A. Everitt,et al.  SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix , 1989, The Journal of cell biology.

[17]  D E Ingber,et al.  Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix , 1989, The Journal of cell biology.

[18]  M. Iruela-Arispe,et al.  Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  H. Kleinman,et al.  Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures , 1988, The Journal of cell biology.

[20]  D. Rifkin,et al.  Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis , 1988, The Journal of cell biology.

[21]  M. Young,et al.  Isolation of the osteonectin gene: evidence that a variable region of the osteonectin molecule is encoded within one exon. , 1988, Biochemistry.

[22]  L. Orci,et al.  Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells , 1987, The Journal of cell biology.

[23]  P. Holland,et al.  In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization , 1987, The Journal of cell biology.

[24]  R. Timpl,et al.  Solubilization of protein BM‐40 from a basement membrane tumor with cheating agents and evidence for its identity with osteonectin and SPARC , 1987, FEBS letters.

[25]  D. Gospodarowicz,et al.  Structural characterization and biological functions of fibroblast growth factor. , 1987, Endocrine reviews.

[26]  P. Jensen,et al.  Migrating keratinocytes express urokinase-type plasminogen activator. , 1987, The Journal of investigative dermatology.

[27]  J. Folkman,et al.  Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Timpl,et al.  Purification and tissue distribution of a small protein (BM-40) extracted from a basement membrane tumor. , 1986, European journal of biochemistry.

[29]  M. Presta,et al.  Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration , 1986, Molecular and cellular biology.

[30]  L. Orci,et al.  Basic fibroblast growth factor induces angiogenesis in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Elliott,et al.  Developmental and transformation‐sensitive expression of the Sparc gene on mouse chromosome 11. , 1986, The EMBO journal.

[32]  B. Hogan,et al.  Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell ‘culture shock’ glycoprotein of Mr 43,000. , 1986, The EMBO journal.

[33]  R. Bramson,et al.  Endothelial cell injury in vitro is associated with increased secretion of an Mr 43,000 glycoprotein ligand , 1986, Journal of cellular physiology.

[34]  M. Presta,et al.  Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Z. Werb,et al.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.

[36]  O. Saksela,et al.  Plasminogen activation and regulation of pericellular proteolysis. , 1985, Biochimica et biophysica acta.

[37]  K. Mann,et al.  Isolation and characterization of native adult osteonectin. , 1985, The Journal of biological chemistry.

[38]  J. Folkman,et al.  What is the role of endothelial cells in angiogenesis? , 1984, Laboratory investigation; a journal of technical methods and pathology.

[39]  P. Bornstein,et al.  Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. , 1984, The Journal of biological chemistry.

[40]  D. Loskutoff,et al.  Cultured bovine endothelial cells produce both urokinase and tissue- type plasminogen activators , 1982, The Journal of cell biology.

[41]  L. Liotta,et al.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. , 1981, Cancer research.

[42]  H. Kleinman,et al.  Osteonectin, a bone-specific protein linking mineral to collagen , 1981, Cell.

[43]  E. Dowdle,et al.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. , 1980, Analytical biochemistry.

[44]  Z. Werb,et al.  Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. , 1977, The New England journal of medicine.